上海凯赛生物技术股份有限公司 2025年第一季度报告

Core Viewpoint - The company, Shanghai Kaisa Biotechnology Co., Ltd., has released its quarterly report for the first quarter of 2025, ensuring the accuracy and completeness of the financial information presented [2][3]. Financial Data - The financial statements for the first quarter of 2025 have not been audited [3]. - The company reported a net profit of 0 yuan for the merged entity prior to the merger, consistent with the previous period [6]. Shareholder Information - The company has completed the registration of 137,911,755 new shares issued to specific investors as of March 31, 2025 [5]. Audit Opinion - The financial statements are categorized as unaudited, indicating that they have not undergone an external audit process [6].